GLP-1 Receptor Agonist Improves Metabolic Disease in a Pre-clinical Model of Lipodystrophy
A. Roumane, G. D. Mcilroy, N. Sommer, W. Han, L. K. Heisler, J. J. Rochford
This study shows that liraglutide, a GLP-1R agonist, improves metabolic disease in seipin knockout mice, a model of lipodystrophy, by enhancing insulin secretion and reducing liver fibrosis.
bioRxiv · Sep 1, 2023Pharmacology & Toxicology